134 related articles for article (PubMed ID: 29494986)
1. Low expression of GFI-1 Gene is associated with Panobinostat-resistance in acute myeloid leukemia through influencing the level of HO-1.
Cheng B; Tang S; Zhe N; Ma D; Yu K; Wei D; Zhou Z; Lu T; Wang J; Fang Q
Biomed Pharmacother; 2018 Apr; 100():509-520. PubMed ID: 29494986
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of panobinostat and bortezomib on chemoresistant acute myelogenous leukemia cells via AKT and NF-κB pathways.
Jiang XJ; Huang KK; Yang M; Qiao L; Wang Q; Ye JY; Zhou HS; Yi ZS; Wu FQ; Wang ZX; Zhao QX; Meng FY
Cancer Lett; 2012 Dec; 326(2):135-42. PubMed ID: 22863538
[TBL] [Abstract][Full Text] [Related]
3. Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia.
Zhe N; Wang J; Chen S; Lin X; Chai Q; Zhang Y; Zhao J; Fang Q
Hematology; 2015 Aug; 20(7):384-91. PubMed ID: 26218201
[TBL] [Abstract][Full Text] [Related]
4. Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells.
Fiskus W; Rao R; Fernandez P; Herger B; Yang Y; Chen J; Kolhe R; Mandawat A; Wang Y; Joshi R; Eaton K; Lee P; Atadja P; Peiper S; Bhalla K
Blood; 2008 Oct; 112(7):2896-905. PubMed ID: 18660379
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of panobinostat and marizomib in acute myeloid leukemia and bortezomib-resistant models.
Corrales-Medina FF; Manton CA; Orlowski RZ; Chandra J
Leuk Res; 2015 Mar; 39(3):371-9. PubMed ID: 25612941
[TBL] [Abstract][Full Text] [Related]
6. HO-1 underlies resistance of AML cells to TNF-induced apoptosis.
Rushworth SA; MacEwan DJ
Blood; 2008 Apr; 111(7):3793-801. PubMed ID: 18202225
[TBL] [Abstract][Full Text] [Related]
7. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.
Fiskus W; Wang Y; Sreekumar A; Buckley KM; Shi H; Jillella A; Ustun C; Rao R; Fernandez P; Chen J; Balusu R; Koul S; Atadja P; Marquez VE; Bhalla KN
Blood; 2009 Sep; 114(13):2733-43. PubMed ID: 19638619
[TBL] [Abstract][Full Text] [Related]
8. Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo.
Qi W; Zhang W; Edwards H; Chu R; Madlambayan GJ; Taub JW; Wang Z; Wang Y; Li C; Lin H; Ge Y
Cancer Biol Ther; 2015; 16(12):1784-93. PubMed ID: 26529495
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylases 1 and 2 cooperate in regulating BRCA1, CHK1, and RAD51 expression in acute myeloid leukemia cells.
Zhao J; Xie C; Edwards H; Wang G; Taub JW; Ge Y
Oncotarget; 2017 Jan; 8(4):6319-6329. PubMed ID: 28030834
[TBL] [Abstract][Full Text] [Related]
10. Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells.
Lee MC; Kuo YY; Chou WC; Hou HA; Hsiao M; Tien HF
J Leukoc Biol; 2014 Jan; 95(1):105-15. PubMed ID: 24018353
[TBL] [Abstract][Full Text] [Related]
11. Panobinostat for the treatment of acute myelogenous leukemia.
Morabito F; Voso MT; Hohaus S; Gentile M; Vigna E; Recchia AG; Iovino L; Benedetti E; Lo-Coco F; Galimberti S
Expert Opin Investig Drugs; 2016 Sep; 25(9):1117-31. PubMed ID: 27485472
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic drug combination induces remission in mouse xenograft models of pediatric acute myeloid leukemia.
Gopalakrishnapillai A; Kolb EA; McCahan SM; Barwe SP
Leuk Res; 2017 Jul; 58():91-97. PubMed ID: 28505595
[TBL] [Abstract][Full Text] [Related]
13. The synergy of panobinostat plus doxorubicin in acute myeloid leukemia suggests a role for HDAC inhibitors in the control of DNA repair.
Maiso P; Colado E; Ocio EM; Garayoa M; Martín J; Atadja P; Pandiella A; San-Miguel JF
Leukemia; 2009 Dec; 23(12):2265-74. PubMed ID: 19812608
[TBL] [Abstract][Full Text] [Related]
14. Crucial role of HO-1/IRF4-dependent apoptosis induced by panobinostat and lenalidomide in multiple myeloma.
Tang S; Ma D; Cheng B; Fang Q; Kuang X; Yu K; Wang W; Hu B; Wang J
Exp Cell Res; 2018 Feb; 363(2):196-207. PubMed ID: 29317217
[TBL] [Abstract][Full Text] [Related]
15. Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway.
Wang H; Liu YC; Zhu CY; Yan F; Wang MZ; Chen XS; Wang XK; Pang BX; Li YH; Liu DH; Gao CJ; Liu SJ; Dou LP
J Exp Clin Cancer Res; 2020 Dec; 39(1):278. PubMed ID: 33298132
[TBL] [Abstract][Full Text] [Related]
16. FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism.
Rushworth SA; Zaitseva L; Langa S; Bowles KM; MacEwan DJ
Oncotarget; 2010 Sep; 1(5):359-366. PubMed ID: 21307400
[TBL] [Abstract][Full Text] [Related]
17. Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51.
Xie C; Drenberg C; Edwards H; Caldwell JT; Chen W; Inaba H; Xu X; Buck SA; Taub JW; Baker SD; Ge Y
PLoS One; 2013; 8(11):e79106. PubMed ID: 24244429
[TBL] [Abstract][Full Text] [Related]
18. Crucial role of heme oxygenase-1 in the sensitivity of acute myeloid leukemia cell line Kasumi-1 to ursolic acid.
Ma D; Fang Q; Li Y; Wang J; Sun J; Zhang Y; Hu X; Wang P; Zhou S
Anticancer Drugs; 2014 Apr; 25(4):406-14. PubMed ID: 24413389
[TBL] [Abstract][Full Text] [Related]
19. Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia.
Salerno L; Romeo G; Modica MN; Amata E; Sorrenti V; Barbagallo I; Pittalà V
Eur J Med Chem; 2017 Dec; 142():163-178. PubMed ID: 28756878
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase 1 induced by neddylation inhibition contributes to drug resistance in acute myelogenous leukemia.
Lai QY; He YZ; Peng XW; Zhou X; Liang D; Wang L
Cell Commun Signal; 2019 Jul; 17(1):86. PubMed ID: 31358016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
